Clinical Trial

A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects

Name: A Comparative Pharmacokinetic Study of CM326 in Healthy Subjects — clinical trial record (NCT07560033)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, open-label, parallel-controlled study to compare the PK, safety, and immunogenicity of CM326 administered via different delivery devices in healthy subjects.

Trial Details

NCT Number	NCT07560033
Lead Sponsor	CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Conditions	Healthy Subjects
Enrollment	192 participants
Start Date	2026-04-20
Primary Completion	2026-10-01 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-30